Clinical Trial Detail

NCT ID NCT02264613
Title Safety Study of ALRN-6924 in Patients With Advanced Solid Tumors
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors Aileron Therapeutics
Indications

Advanced Solid Tumor

Therapies

ALRN-6924

Age Groups: adult

Additional content available in CKB BOOST